Jasper Therapeutics CFO Herb Cross resigns Oct 9; CEO Jeet Mahal takes interim PFO role

Jasper Therapeutics, Inc.

CFO, principal financial and accounting officer and corporate secretary Herb Cross resigned effective October 9, 2026 to pursue other professional endeavors.
Board acted September 28, 2026: CEO Jeet Mahal named interim Principal Financial Officer and VP Finance Rick Ruiz interim Principal Accounting Officer.
Chief Operating Officer Matthew Ros was appointed interim Corporate Secretary; all three appointments take effect on Cross's resignation date.
Ruiz, 62, joined Jasper in 2024 after VP Finance roles at Atreca and controller work at Audible Magic; he keeps a $364,000 base salary and equity eligibility.
No new equity award was granted to Ruiz for the interim promotion, and no permanent CFO replacement was named.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.